Press release
Strong Growth Ahead: Poly ADP-Ribose Polymerase (PARP) Inhibitor Market Size To Grow At Arecord 11.7% Cagr By 2029
Poly ADP-Ribose Polymerase (PARP) Inhibitor Market
How Big Is the Poly ADP-Ribose Polymerase (PARP) Inhibitor Market Size Expected to Be by 2034?
The poly ADP-ribose polymerase (PARP) inhibitor market, valued at $8.39 billion in 2024, is expected to grow to $9.41 billion in 2025, reflecting a CAGR of 12.1%. This market's growth has been influenced by clinical research, regulatory approvals, competitive market forces, drug combinations, and patient advocacy efforts.
The poly ADP-ribose polymerase (PARP) inhibitor market is forecast to grow rapidly, reaching $14.67 billion in 2029 at a CAGR of 11.7%. The expansion of indications, personalized medicine, biomarker development, and health economics are key growth drivers. Major trends in the forecast period include precision medicine, immunotherapy advancements, targeted therapies, AI in drug discovery, and patient-centric healthcare approaches.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15637
What Are the Emerging Segments Within the Poly ADP-Ribose Polymerase (PARP) Inhibitor Market?
The poly ADP-ribose polymerase (PARP) inhibitor market covered in this report is segmented -
1) By Drug Type: Talazoparib, Veliparib, Olaparib, Other Drug Types
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Ovarian Cancer, Breast Cancer, Other Applications
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Talazoparib: Talazoparib For Breast Cancer, Talazoparib For Ovarian Cancer, Talazoparib For Prostate Cancer, Talazoparib For Other Cancers
2) By Veliparib: Veliparib For Breast Cancer, Veliparib For Ovarian Cancer, Veliparib For Non-Small Cell Lung Cancer (Nsclc), Veliparib For Other Cancers
3) By Olaparib: Olaparib For Breast Cancer (Her2-negative), Olaparib For Ovarian Cancer (Brca-mutated), Olaparib For Prostate Cancer (Brca-Mutated), Olaparib For Pancreatic Cancer (Brca-Mutated), Olaparib For Other Cancers
4) By Other Drug Types: Niraparib, Rucaparib, Pembrolizumab (Combination Therapy With Parp Inhibitors), Other Parp Inhibitors (Emerging Drugs In Clinical Trials)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15637&type=smp
What Long-Term Drivers Are Shaping Poly ADP-Ribose Polymerase (PARP) Inhibitor Market Trends?
The growing incidence of ovarian cancer is projected to boost the poly ADP-ribose polymerase (PARP) inhibitor market. Ovarian cancer, a malignant tumor originating in the ovaries, is increasing due to genetic factors, aging populations, environmental exposures, and hormonal imbalances. PARP inhibitors are used to treat ovarian cancer, particularly in patients with BRCA mutations, as they target DNA repair mechanisms and enhance tumor cell death. For example, a report from the World Ovarian Cancer Coalition in February 2024 forecasts a 70% increase in annual ovarian cancer-related deaths by 2022, with 350,956 projected deaths. This rise in ovarian cancer prevalence is expected to fuel the growth of the PARP inhibitor market.
Who Are the Top Competitors in Key Poly ADP-Ribose Polymerase (PARP) Inhibitor Market Segments?
Major companies operating in the Poly ADP-ribose polymerase (PARP) inhibitor market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Merck KGaA, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Genentech Inc., BioMarin Pharmaceutical Inc., Seattle Genetics Inc., Medivation Inc., Myriad Genetics Inc., PharmaMar S.A., Clovis Oncology, Nektar Therapeutics, Loxo Oncology Inc., Tolero Pharmaceuticals Inc., Everest Pharmaceuticals, Verastem Inc
What Are the Latest Developing Trends in the Poly ADP-Ribose Polymerase (PARP) Inhibitor Market?
In the poly ADP-ribose polymerase (PARP) inhibitor market, companies are developing generic inhibitors to provide tailored treatments for cancer patients with specific genetic mutations. For instance, in March 2024, Zydus Lifesciences launched Olaparib under the IBYRA brand, aimed at patients with specific genetic mutations in cancers like breast, ovarian, and prostate. This drug targets HRD-positive and BRACA mutations, offering a more personalized and effective treatment approach.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/poly-adp-ribose-polymerase-parp-inhibitor-global-market-report
Which Regions Are Becoming Hubs for Poly ADP-Ribose Polymerase (PARP) Inhibitor Market Innovation?
North America was the largest region in the poly ADP-ribose polymerase (PARP) inhibitor market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Poly ADP-ribose polymerase (PARP) inhibitor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Poly ADP-Ribose Polymerase (PARP) Inhibitor Market?
2. What is the CAGR expected in the Poly ADP-Ribose Polymerase (PARP) Inhibitor Market?
3. What Are the Key Innovations Transforming the Poly ADP-Ribose Polymerase (PARP) Inhibitor Industry?
4. Which Region Is Leading the Poly ADP-Ribose Polymerase (PARP) Inhibitor Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Poly ADP-Ribose Polymerase (PARP) Inhibitor Market Size To Grow At Arecord 11.7% Cagr By 2029 here
News-ID: 4041374 • Views: …
More Releases from The Business Research Company
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diamond Market Through 2025?
In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate…
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025?
In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion…
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Professional Street Sweeper Market Size By 2025?
The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)…
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
More Releases for Poly
Poly(vinyl Acetate) Market Size Report 2025
On Mar 8, 2025, Global Info Research released a research report titled "Global Poly(vinyl Acetate) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Poly(vinyl Acetate) market from 2020 to 2031. Including the market size and development trends of Poly(vinyl Acetate) Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a…
Poly Aluminium Chloride Market Research Report 2023
Polyaluminium Chloride Market
Polyaluminium chloride (PAC) is manufactured in both liquid and powder form. The product is used in deodorants and antiperspirants, as a flocculant in water purification, in treatment of drinking / potable water, wastewater treatment and paper sizing.
In this report, poly alumnium chloride is classified into liquid and powder type. All the poly alumnium chloride products are converted into 30% Al2O3 content.
Due to the COVID-19 pandemic, the global…
Poly-Vents Market to Witness Remarkable Growth | Filtration Group Corporation; P …
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Poly-Vents Market Analysis and Forecast, 2020 – 2027”. In this report, Researchers have analysed Strength, Weakness, opportunities and threats in the market and provides the unbiased picture of the market with the informative knowledge. The Poly-Vents Market report additionally states import/trade utilization, free market activity figures, cost, value, volume and gross edges.
The study bridges the historical…
Poly-Vents Market To Witness Astonishing Growth | Competitive Outlook By Filtrat …
The Latest survey report on Poly-Vents Market?research gives a holistic overview of the growth and other aspects of the industry in vital countries (regions). The regions provided in this market document show the geographical boundaries across the globe. This report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, customer inclinations, motivating factors for customers, competitor strategies, brand positioning, future trends, customer…
Poly Adenosine Diphosphate Ribose Polymerase Market Drivers
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair…
Poly Adenosine Diphosphate Ribose Polymerase Market Drivers
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair…
